Eva Isaksson
Impact in
- Rehabilitation top 5%
- Stroke Rehabilitation and Recovery
-
- Botulinum Toxin and Related Neurological Disorders
- Neurological Disorders and Treatments
Papers in
-
- Acute Ischemic Stroke Management 8
-
- Stroke Rehabilitation and Recovery 7
- Co-authors
- Erik Lundström (9 shared papers)Per Näsman (8 shared papers)Per Wester (6 shared papers)Bo von Schoultz (5 shared papers)E. von Schoultz (4 shared papers)Gillian Mead (5 shared papers)Maree L. Hackett (5 shared papers)Lena Sahlin (3 shared papers)
- Journals
- Trials (4 papers)Breast Cancer Research and Treatment (2 papers)The Lancet Neurology (2 papers)Cytopathology (1 paper)BMJ Open (1 paper)
- Partner nations
- SwedenAustraliaUnited Kingdom
In The Last Decade
Eva Isaksson
16 papers receiving 281 citations
Peers
Comparison fields: 5 of 73
- Rehabilitation 110
- Neurology 45
- Internal Medicine 20
- Epidemiology 113
- Neurology 44
Countries citing papers authored by Eva Isaksson
This map shows the geographic impact of Eva Isaksson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Isaksson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Isaksson more than expected).
Fields of papers citing papers by Eva Isaksson
This network shows the impact of papers produced by Eva Isaksson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Isaksson. The network helps show where Eva Isaksson may publish in the future.
Co-authors
The 25 scholars most cited alongside Eva Isaksson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 97 | |
| 2 | 2003 | 33 | |
| 3 | 2016 | 29 | |
| 4 | 2019 | 25 | |
| 5 | 2003 | 21 | |
| 6 | 2017 | 18 | |
| 7 | 2002 | 15 | |
| 8 | 2020 | 13 | |
| 9 | 2021 | 12 | |
| 10 | 2002 | 11 | |
| 11 | 1999 | 7 | |
| 12 | 2018 | 5 | |
| 13 | 2020 | 4 | |
| 14 | 2023 | 3 | |
| 15 | Efficacy of fluoxetine - a randomized controlled trial in stroke (effects) | 2020 | 2 |
| 16 | 2024 | 1 |
About Eva Isaksson
Eva Isaksson is a scholar working on Epidemiology, Rehabilitation, Oncology, Genetics and Neurology, having authored 16 papers that have together received 296 indexed citations. Recurring topics across this work include Acute Ischemic Stroke Management (8 papers), Stroke Rehabilitation and Recovery (7 papers), Estrogen and related hormone effects (4 papers), Cancer Risks and Factors (3 papers), Cardiac Arrhythmias and Treatments (2 papers), Atrial Fibrillation Management and Outcomes (2 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers) and Botulinum Toxin and Related Neurological Disorders (2 papers). The work is most often cited by research in Rehabilitation (110 citations), Neurology (45 citations), Internal Medicine (20 citations), Epidemiology (113 citations) and Neurology (44 citations). Eva Isaksson has collaborated with scholars based in Sweden, Australia and United Kingdom. Frequent co-authors include Erik Lundström, Per Näsman, Per Wester, Bo von Schoultz, E. von Schoultz, Gillian Mead, Maree L. Hackett, Lena Sahlin, Graeme J. Hankey and Martin Dennis. Their work appears in journals such as Trials, Breast Cancer Research and Treatment, The Lancet Neurology, Cytopathology and BMJ Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.